{
    "organizations": [],
    "uuid": "6c8f06143ad3b1f1db695eb3ec2943efa26a9b29",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biophytis-updates-on-sara-clinical/brief-biophytis-updates-on-sara-clinical-study-of-sarconeos-in-sarcopenia-idUSFWN1QJ0B7",
    "ord_in_thread": 0,
    "title": "Biophytis Updates On Sara Clinical Study Of Sarconeos In Sarcopenia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - BIOPHYTIS SA:\n* BIOPHYTIS UPDATES ON SARA CLINICAL STUDY OF SARCONEOS IN SARCOPENIA\n* THESE RESULTS DEMONSTRATE THE STRONG POTENTIAL OF SARCONEOS (BIO101) IN THE TREATMENT OF SARCOPENIA\n* THESE RESULTS CONFIRM THE RELEVANCE OF THE SARA-INTEREST INTERNATIONAL CLINICAL STUDY\n* FIRST PATIENT WILL BE ENROLLED IN THE COMING WEEKS * FIRST PATIENT IN CLINICAL STUDY WILL BE ENROLLED IN THE COMING WEEKS Source text : reut.rs/2ozc0LY (Gdynia Newsroom)\n ",
    "published": "2018-03-01T15:06:00.000+02:00",
    "crawled": "2018-03-02T20:24:30.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "biophytis",
        "sa",
        "biophytis",
        "update",
        "sara",
        "clinical",
        "study",
        "sarconeos",
        "sarcopenia",
        "result",
        "demonstrate",
        "strong",
        "potential",
        "sarconeos",
        "bio101",
        "treatment",
        "sarcopenia",
        "result",
        "confirm",
        "relevance",
        "international",
        "clinical",
        "study",
        "first",
        "patient",
        "enrolled",
        "coming",
        "week",
        "first",
        "patient",
        "clinical",
        "study",
        "enrolled",
        "coming",
        "week",
        "source",
        "text",
        "gdynia",
        "newsroom"
    ]
}